NORTHERN TRUST CORP - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,213,204
+26.6%
538,023
+16.9%
0.01%
+25.0%
Q2 2023$21,497,430
+57.1%
460,429
+28.7%
0.00%
+33.3%
Q1 2023$13,688,165
-30.7%
357,767
-0.7%
0.00%
-25.0%
Q4 2022$19,743,180
+119.2%
360,277
+36.2%
0.00%
+100.0%
Q3 2022$9,007,000
+290.1%
264,510
+8.3%
0.00%
Q2 2022$2,309,000
-31.0%
244,278
+3.5%
0.00%
-100.0%
Q1 2022$3,347,000
-36.6%
235,925
-5.5%
0.00%0.0%
Q4 2021$5,283,000
-4.3%
249,774
+1.1%
0.00%0.0%
Q3 2021$5,520,000
-13.4%
246,943
-3.9%
0.00%0.0%
Q2 2021$6,376,000
+26.3%
257,012
+47.7%
0.00%0.0%
Q1 2021$5,047,000
+4.6%
174,000
-6.9%
0.00%0.0%
Q4 2020$4,823,000
-18.4%
186,968
-2.7%
0.00%0.0%
Q3 2020$5,914,000
+54.1%
192,084
+24.7%
0.00%0.0%
Q2 2020$3,839,000
+81.3%
154,052
+54.3%
0.00%0.0%
Q1 2020$2,117,000
+37.9%
99,862
+44.4%
0.00%
Q4 2019$1,535,000
-3.5%
69,161
-1.1%
0.00%
Q3 2019$1,590,000
+632.7%
69,936
+517.4%
0.00%
Q2 2019$217,00011,3280.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders